The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

EuroIntervention 2021;17:785-786. DOI: 10.4244/EIJV17I10A135

1. Quebec Heart & Lung Institute, Laval University, Quebec City, QC, Canada; 2. Hospital Clínic of Barcelona, Barcelona, Spain
Valve-in-valve transcatheter aortic valve implantation (VIV-TAVI) has become the preferred treatment for the majority of patients with surgical aortic bioprosthesis dysfunction. While VIV-TAVI is associated with significant clinical improvements in the majority of patients, a high rate of suboptimal haemodynamic results defined as a residual gradient ≥20 mmHg has been reported, particularly among patients with small stented surgical valves. Bioprosthetic valve fracture (BVF), which consists of fracturing the ring of the surgical valve using a high-pressure non-compliant balloon, has emerged as a technique for improving valve haemodynamics following VIV-TAVI1. However, data on BVF have been limited to small series with ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)